These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 33891985)

  • 1. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review.
    Chong WH; Neu KP
    J Hosp Infect; 2021 Jul; 113():115-129. PubMed ID: 33891985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and the value of microbiological examinations of COVID-19 associated pulmonary aspergillosis in critically ill patients in intensive care unit: the appropriate microbiological examinations are crucial for the timely diagnosis of CAPA.
    Zhou X; Wu X; Chen Z; Cui X; Cai Y; Liu Y; Weng B; Zhan Q; Huang L
    Front Cell Infect Microbiol; 2023; 13():1287496. PubMed ID: 38076456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
    Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
    Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City.
    Vélez Pintado M; Camiro-Zúñiga A; Aguilar Soto M; Cuenca D; Mercado M; Crabtree-Ramirez B;
    Med Mycol; 2021 Jul; 59(8):828-833. PubMed ID: 33724423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity.
    Machado M; Valerio M; Álvarez-Uría A; Olmedo M; Veintimilla C; Padilla B; De la Villa S; Guinea J; Escribano P; Ruiz-Serrano MJ; Reigadas E; Alonso R; Guerrero JE; Hortal J; Bouza E; Muñoz P;
    Mycoses; 2021 Feb; 64(2):132-143. PubMed ID: 33210776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis.
    Chong WH; Saha BK; Neu KP
    Infection; 2022 Feb; 50(1):43-56. PubMed ID: 34570355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19-Associated Pulmonary Aspergillosis (CAPA).
    Dimopoulos G; Almyroudi MP; Myrianthefs P; Rello J
    J Intensive Med; 2021 Oct; 1(2):71-80. PubMed ID: 36785564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study.
    Bartoletti M; Pascale R; Cricca M; Rinaldi M; Maccaro A; Bussini L; Fornaro G; Tonetti T; Pizzilli G; Francalanci E; Giuntoli L; Rubin A; Moroni A; Ambretti S; Trapani F; Vatamanu O; Ranieri VM; Castelli A; Baiocchi M; Lewis R; Giannella M; Viale P;
    Clin Infect Dis; 2021 Dec; 73(11):e3606-e3614. PubMed ID: 32719848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation.
    Feys S; Lagrou K; Lauwers HM; Haenen K; Jacobs C; Brusselmans M; Debaveye Y; Hermans G; Hoenigl M; Maertens J; Meersseman P; Peetermans M; Spriet I; Vandenbriele C; Vanderbeke L; Vos R; Van Wijngaerden E; Wilmer A; Wauters J
    Clin Infect Dis; 2024 Feb; 78(2):361-370. PubMed ID: 37691392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiological diagnosis of pulmonary invasive aspergillosis in critically ill patients with severe SARS-CoV-2 pneumonia: a bronchoalveolar study.
    Estella Á; Martín-Loeches I; Núñez MR; García CG; Pesaresi LM; Escors AA; Prieto MDL; Calvo JMS
    Ann Clin Microbiol Antimicrob; 2023 Oct; 22(1):90. PubMed ID: 37817167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study.
    Tamayo-Velasco Á; López-Herrero R; Gómez-García LM; Sánchez-de Prada L; Aguilar-Monserrate G; Martín-Fernández M; Bardají-Carrillo M; Álvaro-Meca A; Tamayo E; Resino S; Miramontes-González JP; Peñarrubia-Ponce MJ
    J Infect Public Health; 2024 Jun; 17(6):939-946. PubMed ID: 38613930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19-Associated Invasive Aspergillosis: Data from the UK National Mycology Reference Laboratory.
    Borman AM; Palmer MD; Fraser M; Patterson Z; Mann C; Oliver D; Linton CJ; Gough M; Brown P; Dzietczyk A; Hedley M; McLachlan S; King J; Johnson EM
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.
    Verweij PE; Brüggemann RJM; Azoulay E; Bassetti M; Blot S; Buil JB; Calandra T; Chiller T; Clancy CJ; Cornely OA; Depuydt P; Koehler P; Lagrou K; de Lange D; Lass-Flörl C; Lewis RE; Lortholary O; Liu PL; Maertens J; Nguyen MH; Patterson TF; Rijnders BJA; Rodriguez A; Rogers TR; Schouten JA; Wauters J; van de Veerdonk FL; Martin-Loeches I
    Intensive Care Med; 2021 Aug; 47(8):819-834. PubMed ID: 34160631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave.
    Bretagne S; Sitbon K; Botterel F; Dellière S; Letscher-Bru V; Chouaki T; Bellanger AP; Bonnal C; Fekkar A; Persat F; Costa D; Bourgeois N; Dalle F; Lussac-Sorton F; Paugam A; Cassaing S; Hasseine L; Huguenin A; Guennouni N; Mazars E; Le Gal S; Sasso M; Brun S; Cadot L; Cassagne C; Cateau E; Gangneux JP; Moniot M; Roux AL; Tournus C; Desbois-Nogard N; Le Coustumier A; Moquet O; Alanio A; Dromer F;
    Microbiol Spectr; 2021 Oct; 9(2):e0113821. PubMed ID: 34668768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina.
    Giusiano G; Fernández NB; Vitale RG; Alvarez C; Ochiuzzi ME; Santiso G; Cabeza MS; Tracogna F; Farías L; Afeltra J; Noblega LM; Giuliano CV; Garcia-Effron G
    Med Mycol; 2022 May; 60(5):. PubMed ID: 35394043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.
    Prattes J; Wauters J; Giacobbe DR; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Reisinger AC; Cornely OA; Lahmer T; Valerio M; Delhaes L; Jabeen K; Steinmann J; Chamula M; Bassetti M; Hatzl S; Rautemaa-Richardson R; Koehler P; Lagrou K; Hoenigl M;
    Clin Microbiol Infect; 2022 Apr; 28(4):580-587. PubMed ID: 34454093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A screening study for COVID-19-associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic.
    Er B; Er AG; Gülmez D; Şahin TK; Halaçlı B; Durhan G; Ersoy EO; Alp A; Metan G; Saribas Z; Arikan-Akdagli S; Hazırolan G; Akıncı SB; Arıyürek M; Topeli A; Uzun Ö
    Mycoses; 2022 Jul; 65(7):724-732. PubMed ID: 35531631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and mortality of COVID-19-associated pulmonary aspergillosis: A systematic review and meta-analysis.
    Mitaka H; Kuno T; Takagi H; Patrawalla P
    Mycoses; 2021 Sep; 64(9):993-1001. PubMed ID: 33896063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and Risk Factors of COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit-A Monocentric Retrospective Observational Study.
    Gregoire E; Pirotte BF; Moerman F; Altdorfer A; Gaspard L; Firre E; Moonen M; Fraipont V; Ernst M; Darcis G
    Pathogens; 2021 Oct; 10(11):. PubMed ID: 34832526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study.
    Lahmer T; Kriescher S; Herner A; Rothe K; Spinner CD; Schneider J; Mayer U; Neuenhahn M; Hoffmann D; Geisler F; Heim M; Schneider G; Schmid RM; Huber W; Rasch S
    PLoS One; 2021; 16(3):e0238825. PubMed ID: 33730058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.